Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry

Purpose. To evaluate toxicity associated with the addition of elective nodal irradiation (ENI) to a hypofractionated regimen for the treatment of prostate cancer. Methods and Materials. Fifty-seven patients received pelvic image-guided IMRT to 50.4 Gy in 28 fractions with a hypofractionated simultan...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrew M. McDonald, Justin M. Bishop, Rojymon Jacob, Michael C. Dobelbower, Robert Y. Kim, Eddy S. Yang, Heather Smith, Xingen Wu, John B. Fiveash
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Prostate Cancer
Online Access:http://dx.doi.org/10.1155/2012/546794
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849689971011616768
author Andrew M. McDonald
Justin M. Bishop
Rojymon Jacob
Michael C. Dobelbower
Robert Y. Kim
Eddy S. Yang
Heather Smith
Xingen Wu
John B. Fiveash
author_facet Andrew M. McDonald
Justin M. Bishop
Rojymon Jacob
Michael C. Dobelbower
Robert Y. Kim
Eddy S. Yang
Heather Smith
Xingen Wu
John B. Fiveash
author_sort Andrew M. McDonald
collection DOAJ
description Purpose. To evaluate toxicity associated with the addition of elective nodal irradiation (ENI) to a hypofractionated regimen for the treatment of prostate cancer. Methods and Materials. Fifty-seven patients received pelvic image-guided IMRT to 50.4 Gy in 28 fractions with a hypofractionated simultaneous boost to the prostate to 70 Gy. Thirty-one patients received prostate-only treatment to 70 Gy in 28 fractions. Results. Median followup was 41.1 months. Early grade ≥2 urinary toxicity rates were 49% (28 of 57) for patients receiving ENI and 58% (18 of 31) for those not (P=0.61). Early grade ≥2 rectal toxicity rates were 40% (23 of 57) and 23% (7 of 31), respectively (P=0.09). The addition of ENI resulted in a 21% actuarial rate of late grade ≥2 rectal toxicity at 4 years, compared to 0% for patients treated to the prostate only (P=0.02). Retrospective daily dosimetry of patients experiencing late rectal toxicity revealed an average increase of 2.67% of the rectal volume receiving 70 Gy compared to the original plan. Conclusions. The addition of ENI resulted in an increased risk of late rectal toxicity. Grade ≥2 late rectal toxicity was associated with worse daily rectal dosimetry compared to the treatment plan.
format Article
id doaj-art-f09a8980aec44fd29ec62bb3c8a3376c
institution DOAJ
issn 2090-3111
2090-312X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Prostate Cancer
spelling doaj-art-f09a8980aec44fd29ec62bb3c8a3376c2025-08-20T03:21:27ZengWileyProstate Cancer2090-31112090-312X2012-01-01201210.1155/2012/546794546794Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily DosimetryAndrew M. McDonald0Justin M. Bishop1Rojymon Jacob2Michael C. Dobelbower3Robert Y. Kim4Eddy S. Yang5Heather Smith6Xingen Wu7John B. Fiveash8Department of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham, 1700 6th Avenue South Birmingham, Birmingham, AL 35249, USABirmingham Southern College, 900 Arkadelphia Road, Birmingham, AL 35254, USADepartment of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham, 1700 6th Avenue South Birmingham, Birmingham, AL 35249, USADepartment of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham, 1700 6th Avenue South Birmingham, Birmingham, AL 35249, USADepartment of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham, 1700 6th Avenue South Birmingham, Birmingham, AL 35249, USADepartment of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham, 1700 6th Avenue South Birmingham, Birmingham, AL 35249, USADepartment of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham, 1700 6th Avenue South Birmingham, Birmingham, AL 35249, USADepartment of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham, 1700 6th Avenue South Birmingham, Birmingham, AL 35249, USADepartment of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham, 1700 6th Avenue South Birmingham, Birmingham, AL 35249, USAPurpose. To evaluate toxicity associated with the addition of elective nodal irradiation (ENI) to a hypofractionated regimen for the treatment of prostate cancer. Methods and Materials. Fifty-seven patients received pelvic image-guided IMRT to 50.4 Gy in 28 fractions with a hypofractionated simultaneous boost to the prostate to 70 Gy. Thirty-one patients received prostate-only treatment to 70 Gy in 28 fractions. Results. Median followup was 41.1 months. Early grade ≥2 urinary toxicity rates were 49% (28 of 57) for patients receiving ENI and 58% (18 of 31) for those not (P=0.61). Early grade ≥2 rectal toxicity rates were 40% (23 of 57) and 23% (7 of 31), respectively (P=0.09). The addition of ENI resulted in a 21% actuarial rate of late grade ≥2 rectal toxicity at 4 years, compared to 0% for patients treated to the prostate only (P=0.02). Retrospective daily dosimetry of patients experiencing late rectal toxicity revealed an average increase of 2.67% of the rectal volume receiving 70 Gy compared to the original plan. Conclusions. The addition of ENI resulted in an increased risk of late rectal toxicity. Grade ≥2 late rectal toxicity was associated with worse daily rectal dosimetry compared to the treatment plan.http://dx.doi.org/10.1155/2012/546794
spellingShingle Andrew M. McDonald
Justin M. Bishop
Rojymon Jacob
Michael C. Dobelbower
Robert Y. Kim
Eddy S. Yang
Heather Smith
Xingen Wu
John B. Fiveash
Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry
Prostate Cancer
title Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry
title_full Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry
title_fullStr Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry
title_full_unstemmed Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry
title_short Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry
title_sort hypofractionated prostate radiotherapy with or without conventionally fractionated nodal irradiation clinical toxicity observations and retrospective daily dosimetry
url http://dx.doi.org/10.1155/2012/546794
work_keys_str_mv AT andrewmmcdonald hypofractionatedprostateradiotherapywithorwithoutconventionallyfractionatednodalirradiationclinicaltoxicityobservationsandretrospectivedailydosimetry
AT justinmbishop hypofractionatedprostateradiotherapywithorwithoutconventionallyfractionatednodalirradiationclinicaltoxicityobservationsandretrospectivedailydosimetry
AT rojymonjacob hypofractionatedprostateradiotherapywithorwithoutconventionallyfractionatednodalirradiationclinicaltoxicityobservationsandretrospectivedailydosimetry
AT michaelcdobelbower hypofractionatedprostateradiotherapywithorwithoutconventionallyfractionatednodalirradiationclinicaltoxicityobservationsandretrospectivedailydosimetry
AT robertykim hypofractionatedprostateradiotherapywithorwithoutconventionallyfractionatednodalirradiationclinicaltoxicityobservationsandretrospectivedailydosimetry
AT eddysyang hypofractionatedprostateradiotherapywithorwithoutconventionallyfractionatednodalirradiationclinicaltoxicityobservationsandretrospectivedailydosimetry
AT heathersmith hypofractionatedprostateradiotherapywithorwithoutconventionallyfractionatednodalirradiationclinicaltoxicityobservationsandretrospectivedailydosimetry
AT xingenwu hypofractionatedprostateradiotherapywithorwithoutconventionallyfractionatednodalirradiationclinicaltoxicityobservationsandretrospectivedailydosimetry
AT johnbfiveash hypofractionatedprostateradiotherapywithorwithoutconventionallyfractionatednodalirradiationclinicaltoxicityobservationsandretrospectivedailydosimetry